This page was created by volunteers like you!
Help us make it even better. To learn more about contributing to MEpedia, click here.
Join the movement
Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
Congratulations!
MEpedia has got over 30 million views as of August 2022!

Hereditary alpha tryptasemia syndrome

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Hereditary Alpha Tryptasemia Syndrome or hereditary α-tryptasemia syndrome or HATS is a genetic and multi-systemic disease caused by an increased copy number α-tryptase-encoding regions on the TPSAB1 (TPSAB1) gene.[1]

Hereditary alpha tryptasemia/familial hypertryptasemia[edit | edit source]

Hereditary alpha tryptasemia (H⍺T or HAT), alternatively known as familial hypertryptasemia (FHT), is common in the general population, affecting around 1 in 20 people, and is often asymptomatic.[2][1][3]

Hereditary alpha tryptasemia syndrome (HATS) is only diagnosed when a cluster of associated symptoms are also present.[1]

Signs and symptoms[edit | edit source]

Hereditary Alpha Tryptasemia Syndrome symptoms include:

The TPSAB1 has also been implicated in unexplained gastrointestinal symptoms and mast cell activation.[4][1][2][3]

Treatment[edit | edit source]

ME/CFS[edit | edit source]

Notable studies[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. Jump up to: 1.0 1.1 1.2 1.3 1.4 "Hereditary Alpha Tryptasemia Syndrome FAQ". National Institute of Allergy and Infectious Diseases. October 17, 2016.
  2. Jump up to: 2.0 2.1 Lyons, Jonathan J.; Yu, Xiaomin; Hughes, JasonD.; Le, Quang T.; Jamil, Ali; Bai, Yun; Ho, Nancy; Zhao, Ming; Liu, Yihui; O'Connell, Michael P.; Trivedi, Neil N. (December 2016). "Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number". Nature Genetics. 48 (12): 1564–1569. doi:10.1038/ng.3696. ISSN 1546-1718. PMC 5397297. PMID 27749843.
  3. Jump up to: 3.0 3.1 Luskin, Kathleen T.; White, Andrew A.; Lyons, Jonathan J. (June 2021). "The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia". The Journal of Allergy and Clinical Immunology. In Practice. 9 (6): 2235–2242. doi:10.1016/j.jaip.2021.03.005. ISSN 2213-2201. PMID 33744473.
  4. Jump up to: 4.0 4.1 Lyons, Jonathan J. (August 1, 2018). "Hereditary Alpha Tryptasemia: Genotyping and Associated Clinical Features". Immunology and Allergy Clinics of North America. Mastocytosis. 38 (3): 483–495. doi:10.1016/j.iac.2018.04.003. ISSN 0889-8561. PMC 6411063. PMID 30007465.